Director, Strategic External Development: Led drug product development for 10+ early- and late-stage assets; delivered emergency-use biologics under accelerated timelines; conducted technical due diligence, managed deviations and CAPAs, selected CDMO partners, and supported global regulatory submissions.
Director, Biopharm Product Development: Directed CMC teams for multiple biologic products, including device integration and shelf-life studies; authored BLA and MAA sections; led robotic sterile filler initiatives and advanced ADC stability comparability assessments.